Essen Health Care and OwnaHealth Partner to Revolutionize Diabetes and Obesity Care in Underserved NYC Communities
-
Essen Health Care forms strategic alliance with OwnaHealth to deliver personalized diabetes and obesity treatment programs to Medicaid populations in the Bronx and underserved areas of New York City.
-
OwnaHealth's ketosis-based program has demonstrated significant clinical outcomes, including 24% reduction in HbA1c levels and minimum 15% weight loss in many patients, along with improved mental health metrics.
-
The partnership provides 24/7 access to virtual healthcare teams and combines AI-driven technology with comprehensive medical, social, and behavioral support to address complex healthcare needs.
In a significant move to address chronic health conditions in underserved communities, Essen Health Care has announced a strategic partnership with OwnaHealth to revolutionize diabetes and obesity treatment for Medicaid populations in the Bronx and other underserved areas of New York City.
The collaboration introduces OwnaHealth's clinically validated methodology, specifically designed to overcome the unique challenges faced by Medicaid populations. Patients will gain access to comprehensive clinical and lifestyle management programs that integrate social, medical, and behavioral support components. The treatment model features round-the-clock support from a virtual team of healthcare professionals, including doctors, nutritionists, and health coaches.
OwnaHealth's personalized, nutritional, ketosis-based approach has yielded impressive results in managing both diabetes and obesity. Clinical data demonstrates a 24% reduction in HbA1c levels among Type II diabetes patients, while many participants have achieved significant weight loss of at least 15% of their body weight. Notably, some patients have successfully reduced or eliminated their medication requirements entirely.
Beyond physical health improvements, the program has shown substantial positive impact on mental well-being. Participants have experienced a 35% reduction in depression scores and a 45% decrease in anxiety scores. The program maintains strong engagement and retention rates, supported by sophisticated AI-driven technology and engagement tools.
"Our partnership reflects a shared commitment to transforming lives, especially in underserved communities in the Bronx, by addressing diabetes and obesity with a personalized, evidence-based approach that truly works," said Dr. Mariela Glandt, founder and CEO of OwnaHealth.
Dr. Sumir Sahgal, founder and chief medical officer of Essen Health Care, emphasized the strategic importance of the partnership: "Our collaboration with OwnaHealth allows us to enhance our ability to address two of the most pressing chronic conditions, diabetes and obesity, by leveraging innovative, personalized care models that empower our patients to lead healthier lives."

Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Related Topics
Reference News
[1]
Essen Health Care collaborates to transform diabetes and obesity treatment
finance.yahoo.com · Feb 19, 2025